Literature DB >> 33876530

Appraisal of clinical practice guidelines for the evaluation and management of neck masses in children.

Max Shin1, Aman Prasad1, Gabriel R Arguelles1, Jonathan J Wakim1, Kevin Chorath2, Alvaro Moreira3, Karthik Rajasekaran2,4.   

Abstract

AIM: The purpose of this systematic review was to use the Appraisal of Guidelines for Research and Evaluation tool to assess the methodological quality of clinical practice guidelines (CPGs) for the workup and management of paediatric neck masses.
METHODS: MEDLINE, Embase, Cochrane and grey literature were searched to identify CPG incorporating paediatric neck masses. Four authors with previous training of the Appraisal of Guidelines for Research and Evaluation tool evaluated the included studies.
RESULTS: Nine studies met inclusion criteria. The highest scoring domains were 'Scope and Purpose' (74.0 ± 4.5) and 'Clarity of Presentation' (72.9 ± 6.3). The lowest scoring domains were 'Rigour and Development' (18.8 ± 7.5) and 'Applicability' (23.7 ± 6.1). One study was 'High' quality, three received scores of 'Average' and five were found to be 'Low' quality.
CONCLUSION: The majority of paediatric neck mass CPGs were low to average quality. The domains in need of greatest improvement were 'Rigour and Development' and 'Applicability', suggesting significant concerns in current CPGs focused on paediatric neck masses.
© 2021 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).

Entities:  

Keywords:  AGREE II; clinical practice guideline; paediatric cervical lymphadenopathy; paediatric neck mass

Mesh:

Year:  2021        PMID: 33876530     DOI: 10.1111/jpc.15516

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  1 in total

1.  A systematic quality appraisal of clinical practice guidelines for Ménière's disease using the AGREE II instrument.

Authors:  Louis-Xavier Barrette; Katherine Xu; Neeraj Suresh; Jacob Harris; Kevin T Chorath; Alvaro G Moreira; Karthik Rajasekaran
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-10-18       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.